Remove 2016 Remove BioTech Remove Health Policy Remove Survey
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. A 2018 national survey found that 39% of U.S. Yet the trust relationship with technology companies, even after the 2016 Cambridge Analytica event, is different and it’s clearly stronger than it is with health insurers. But the U.S.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Note that most people view pharma companies working on a coronavirus vaccine as balancing profit with public good, compared with drug companies in general (December 2020 tracking data compared with July 2020 survey data).